Dedicated to creating safer nicotine delivery. Through innovation and design, our disruptive technology will aid the decline of tobacco harm and has the potential to save millions of lives which accounts for the single most preventable cause of premature death globally.

Using decades of expertise and experience in the nicotine and pharmaceuticals industries, Ventus Medical is at the forefront of safe and effective nicotine delivery.

Ventus Medicals principle development, ENHALE, is currently undergoing regulatory review in the UK and shortly within Europe, marking the first innovation in licenced medicine in over a decade.

At Ventus Medical, we’re passionate about public health. Our team are all united on a mission to develop safer and more effective solutions to facilitate significant tobacco harm reduction in smokers across the world.

We share WHO’s belief that ‘every person should be able to breathe tobacco-smoke-free air’ – but not all nicotine-containing products are created equally.

We are committed to exceeding regulatory requirements and being at the forefront of innovation and patient insights. You can trust us to deliver on our promises at every step of our journey to a smoke free future.